Literature DB >> 1693817

Immunohistochemical demonstration of peptidylarginine deiminase in human sweat glands.

Y Urano1, K Watanabe, A Sakaki, S Arase, Y Watanabe, F Shigemi, K Takeda, K Akiyama, T Senshu.   

Abstract

Human skin is known to contain protein-bound citrulline. This is the product of enzymatic deimination of arginine residues catalyzed by peptidylarginine deiminase. We probed frozen sections of human skin with a rabbit antiserum raised to rat skeletal muscle peptidylarginine deiminase using the avidin-biotin-peroxidase complex technique. This led us to interesting findings. No staining was observed in epidermis, inner root sheaths of hair follicles, sebaceous glands, and hair erector muscle. However, we noticed specific staining of the cytoplasm of secretory and myoepithelial cells of both eccrine and apocrine sweat glands. The procedure also stained neoplastic cells present in specimens dissected from extramammary Paget's disease. The data mean that peptidylarginine deiminase may be used as a new marker in the classification of skin neoplasms showing sweat gland differentiation. Possible localization of multiple types of peptidylarginine deiminases in human skin is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693817     DOI: 10.1097/00000372-199006000-00005

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

1.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population.

Authors:  L Caponi; E Petit-Teixeira; M Sebbag; F Bongiorni; S Moscato; F Pratesi; C Pierlot; J Osorio; S Chapuy-Regaud; M Guerrin; F Cornelis; G Serre; P Migliorini
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

Review 3.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

Review 4.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Authors:  Shu Wang; Yanming Wang
Journal:  Biochim Biophys Acta       Date:  2013-07-13

5.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

6.  The synovium in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Open Rheumatol J       Date:  2011-12-30

7.  A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.

Authors:  Sharad Kholia; Samireh Jorfi; Paul R Thompson; Corey P Causey; Anthony P Nicholas; Jameel M Inal; Sigrun Lange
Journal:  J Extracell Vesicles       Date:  2015-06-19

Review 8.  Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.

Authors:  Marie-Claire Méchin; Hidenari Takahara; Michel Simon
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.